Speaker Dr Beatriz Molina | Medical Director, Medikas.
Give your patients what they want: The assurance of proven results!
VelaShape III
Mastering body treatments.
And maximizing your ROI.
What VelaShape III is For
Body shaping is booming. Here’s the proven way to bring it to more patients.
Offer them one of the most recognized non-invasive body shaping treatments on the market today. VelaShape® III.
It’s proven to temporarily reduce the appearance of cellulite and thigh circumference1 — areas that women everywhere identify as problem zones — with a deep therapeutic treatment that delivers consistent, reproducible results, with minimal downtime or discomfort.
Key Benefits of VelaShape III
Give your patients what they want:
- The assurance of proven results. With over 10 years of clinical experience, more than 5 million independent treatments, and the most published studies of any medical body shaping device, VelaShape is one of the most recognized non-invasive body shaping treatments on the market today.
- Power and speed. VelaShape III can achieve end point temperature in less time, with up to 150 watts of radiofrequency (RF) power. That reduces the time needed for treatment. And it can reduce the number of treatment sessions by up to 75%.
- Comfort. VelaShape III procedure is comfortable like hot stone massage.
- Convenience. The VelaShape III procedure often takes under an hour.
- All-season treatment. VelaShape III can be used on all skin types in any season and any climate.
Practice Benefits
Gain ROI-boosting benefits your practice needs:
- Entry-level body shaping. VelaShape III treatments are affordably priced, making this a great way to introduce patients to your practice’s body shaping capabilities.
- A potent new revenue stream. Treatments can easily be bundled into packages of four, six, eight, or more.
- Repeat business. The VelaShape III regimen keeps patients coming back, and every visit means more exposure to your other aesthetic offerings.
- Treatment versatility. With VelaShape III, you can temporarily reduce cellulite and do body contouring via temporary circumference reduction for a broad range of ages and skin types.
- Ease of use. VelaShape III’s operator-friendly design lets you delegate procedures to appropriate medical staff.
Six valuable features. One focus: your practice’s success.
Real-time temperature sensor
- Increases patient comfort
- Monitor elevated temperature in the tissue
- Enables a precise treatment
Smart RF™
- Measures patient’s impedance to ensure consistent energy delivery, reducing the number of non-responders
- One of the industry’s first closed-loop RF
Smart and powerful
- Achieve end point temperature quickly with up to 150 W of RF energy
- Intelligent Feedback System™ efficiently sustains end point temperature longer, without patient discomfort,
- Sophisticated design
- Sleek and light profile to fit any size practice
- Ergonomic applicators and foot pedal accessory help to reduce operator fatigue
Featured Resource
Before & After Velashape III Treatment Photos
The VelaShape III effect: look at these clinical results.
Body shaping facts that could reshape your practice.
91% of women say there are things about thier body they want to change or reduce2
1 in 3 say they have considered more than just dieting or exercise to get rid of their fat2
VelaShape III can help you capitalize on the body shaping boom.
Let a Candela product expert show you how to master body treatments and maximize your ROI.
Resources
In The Media
American Spa decided to announce the 2019 winners its Professional Choice Awards. As per their words, "This year, for the awards' 15th anniversary, we followed suit and over the last
In The Media
Money can’t buy happiness, but it can make younger-looking skin a whole lot easier to achieve. What would a typical skin-care regimen look like if your last name was Bezos
Marketing Education
Among the most popular procedures are: Body Shaping/Skin Tightening, Hair Removal, Fractional Skin Rejuvenation and Tattoo Removal. "Through 2019, total male market sales are expected to rise by 11.4% per